Peter van Hoogevest, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany
home / authors / peter-van-hoogevest-pharma-insights-contributor-lipoid-gmbh-frigenstrasse-4-ludwigshafen-am-rhein-germany
Correspondence: Phospholipid Research Center, Im Neuenheimer Feld 515, D-69120 Heidelberg, Germany and PHARMANOVATION Consulting, Kapuzinerstraße 4, D-79618 Rheinfelden (Baden), Germany
Articles
Synthetic Phospholipids as Excipients for Parenteral and Pulmonary Administration
Peter van Hoogevest, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany;Peter Hölig, Pharma Insights Contributor, Lipoid GmbH, Frigenstrasse 4, Ludwigshafen am Rhein, Germany
September 22nd 2021Latest Updated Articles
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: November 12th 2024 | Updated: November 29th 2024
AAPS PharmSci 360: Challenges in Peptide-Based Drugs
Published: November 13th 2024 | Updated: November 29th 2024
Risk-Based Development Supporting Process Qualification for Spray-Dried Dispersion
Published: November 22nd 2024 | Updated: November 29th 2024
Improving Content Uniformity of Morphologically Challenging APIs by Excipient Choice
Published: November 22nd 2024 | Updated: November 29th 2024
The Pharmacy Advantage in Direct-to-Patient Clinical Supply
